IBM, Pfizer form research pact to tackle Parkinson's Disease


IBM Research Data Scientist Eric Clark explores wearable technologies that could help monitor and analyze biological data from study subjects on Thursday, April 7, 2016 at IBM's T. J. Watson Research Center in Yorktown, NY. IBM and Pfizer are teaming up in an effort to give Parkinson's Disease research an analytical edge. The tech titan and the pharmaceutical giant plan to utilize non-invasive wearables to collect and monitor real-time patient data. The end goal of the research project is to advance the way neurological diseases are diagnosed and treated while also speeding up clinical trials to bring new drugs to market. The study, which is expected to last up to three years, will glean patient data from a system of sensors, wearables and mobile devices that will monitor patients around the clock, not just episodically.